Center-Authored Papers

Filters: Author is Reiner, Anne S  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Reding KW, Bernstein JL, Langholz BM, Bernstein L, Haile RW, Begg CB, Lynch CF, Concannon P, Borg A, Teraoka SN et al..  2010.  Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer.. Breast cancer research and treatment. 123(2):491-8. Abstract
Knight JA, Fan J, Malone KE, John EM, Lynch CF, Langballe R, Bernstein L, Shore RE, Brooks JD, Reiner AS et al..  2017.  Alcohol consumption and cigarette smoking in combination: A predictor of contralateral breast cancer risk in the WECARE study.. International journal of cancer. Abstract
Knight JA, Bernstein L, Largent J, Capanu M, Begg CB, Mellemkjaer L, Lynch CF, Malone KE, Reiner AS, Liang X et al..  2009.  Alcohol intake and cigarette smoking and risk of a contralateral breast cancer: The Women's Environmental Cancer and Radiation Epidemiology Study.. American journal of epidemiology. 169(8):962-8. Abstract
Robson ME, Reiner AS, Brooks JD, Concannon PJ, John EM, Mellemkjaer L, Bernstein L, Malone KE, Knight JA, Lynch CF et al..  2017.  Association of Common Genetic Variants With Contralateral Breast Cancer Risk in the WECARE Study.. Journal of the National Cancer Institute. 109(10) Abstract
B
Brooks JD, John EM, Mellemkjær L, Reiner AS, Malone KE, Lynch CF, Figueiredo JC, Haile RW, Shore RE, Bernstein JL et al..  2012.  Body mass index and risk of second primary breast cancer: The WECARE Study.. Breast cancer research and treatment. 131(2):571-80. Abstract
Brooks JD, John EM, Mellemkjaer L, Lynch CF, Knight JA, Malone KE, Reiner AS, Bernstein L, Liang X, Shore RE et al..  2016.  Body mass index, weight change, and risk of second primary breast cancer in the WECARE study: influence of estrogen receptor status of the first breast cancer.. Cancer medicine. 5(11):3282-3291. Abstract
C
Brooks JD, Teraoka SN, Bernstein L, Mellemkjær L, Malone KE, Lynch CF, Haile RW, Concannon P, Reiner AS, Duggan DJ et al..  2013.  Common variants in genes coding for chemotherapy metabolizing enzymes, transporters, and targets: a case-control study of contralateral breast cancer risk in the WECARE Study.. Cancer causes & control : CCC. 24(8):1605-14. Abstract
Bernstein JL, Thomas DC, Shore RE, Robson M, Boice JD, Stovall M, Andersson M, Bernstein L, Malone KE, Reiner AS et al..  2013.  Contralateral breast cancer after radiotherapy among BRCA1 and BRCA2 mutation carriers: A WECARE Study Report.. European journal of cancer (Oxford, England : 1990). 49(14):2979-2985. Abstract
D
Stovall M, Smith SA, Langholz BM, Boice JD, Shore RE, Andersson M, Buchholz TA, Capanu M, Bernstein L, Lynch CF et al..  2008.  Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study.. International journal of radiation oncology, biology, physics. 72(4):1021-30. Abstract
H
Reiner AS, Lynch CF, Sisti JS, John EM, Brooks JD, Bernstein L, Knight JA, Hsu L, Concannon P, Mellemkjær L et al..  2017.  Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population.. Breast cancer research : BCR. 19(1):83. Abstract
P
Malone KE, Begg CB, Haile RW, Borg A, Concannon P, Tellhed L, Xue S, Teraoka S, Bernstein L, Capanu M et al..  2010.  Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(14):2404-10. Abstract
R
Bernstein JL, Haile RW, Stovall M, Boice JD, Shore RE, Langholz B, Thomas DC, Bernstein L, Lynch CF, Olsen JH et al..  2010.  Radiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study.. Journal of the National Cancer Institute. 102(7):475-83. Abstract
Panageas KS, Reiner AS, Iwamoto FM, Cloughesy TF, Aldape KD, Rivera AL, Eichler AF, Louis DN, Paleologos NA, Fisher BJ et al..  2014.  Recursive partitioning analysis of prognostic variables in newly diagnosed anaplastic oligodendroglial tumors.. Neuro-oncology. Abstract
Sisti JS, Bernstein JL, Lynch CF, Reiner AS, Mellemkjaer L, Brooks JD, Knight JA, Bernstein L, Malone KE, Woods M et al..  2015.  Reproductive factors, tumor estrogen receptor status and contralateral breast cancer risk: results from the WECARE study.. SpringerPlus. 4:825. Abstract
S
Teraoka SN, Bernstein JL, Reiner AS, Haile RW, Bernstein L, Lynch CF, Malone KE, Stovall M, Capanu M, Liang X et al..  2011.  Single nucleotide polymorphisms associated with risk for contralateral breast cancer in the Women's Environment, Cancer and Radiation Epidemiology (WECARE) study.. Breast cancer research : BCR. 13(6):R114. Abstract
Langballe R, Mellemkjær L, Malone KE, Lynch CF, John EM, Knight JA, Bernstein L, Brooks J, Andersson M, Reiner AS et al..  2016.  Systemic therapy for breast cancer and risk of subsequent contralateral breast cancer in the WECARE Study.. Breast cancer research : BCR. 18(1):65. Abstract
V
Brooks JD, Teraoka SN, Reiner AS, Satagopan JM, Bernstein L, Thomas DC, Capanu M, Stovall M, Smith SA, Wei S et al..  2012.  Variants in activators and downstream targets of ATM, radiation exposure, and contralateral breast cancer risk in the WECARE study.. Human mutation. 33(1):158-164. Abstract
Brooks JD, Teraoka SN, Malone KE, Haile RW, Bernstein L, Lynch CF, Mellemkjær L, Duggan DJ, Reiner AS, Concannon P et al..  2013.  Variants in tamoxifen metabolizing genes: a case-control study of contralateral breast cancer risk in the WECARE study.. International journal of molecular epidemiology and genetics. 4(1):35-48. Abstract
Brooks JD, Bernstein L, Teraoka SN, Knight JA, Mellemkjaer L, John EM, Malone KE, Reiner AS, Lynch CF, Concannon P et al..  2012.  Variation in genes related to obesity, weight and weight change and risk of contralateral breast cancer in the WECARE Study population.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 21(12):2261-2267. Abstract